Jon Cuthbert

Sagimet Biosciences (NASDAQ:SGMT) announced Monday that its China-based partner, Ascletis Pharma, reported positive topline results from a Phase 3 open-label safety study of denifanstat (ASC40) in patients with moderate to severe acne.

Equinor (NYSE:EQNR) has agreed to divest its entire onshore portfolio in Argentina’s prolific Vaca Muerta shale basin to Vista Energy (NYSE:VIST) in a transaction valued at approximately $1.1 billion.

TuHURA Biosciences (NASDAQ:HURA) announced Monday that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead immune-priming candidate, IFx-2.0, for the treatment of stage IIB to stage IV cutaneous melanoma.

Alliance Resource Partners (NASDAQ:ARLP) reported a massive surge in fourth-quarter profitability on Monday, as record oil and gas royalty volumes and improved coal operational efficiency drove a triple-digit increase in net income.

Dublin-based Aptiv (NYSE:APTV), a global technology company focused on enabling a more automated, electrified, and digitalized future, today reported record financial results for the fourth quarter and full year ended December 31, 2025.

Revvity (NYSE:RVTY) reported fourth-quarter and full-year 2025 results on Monday that exceeded Wall Street estimates, bolstered by resilient demand across its life sciences and diagnostics portfolios.

NIO (NYSE:NIO) accelerated into 2026 with a 96.1% year-over-year surge in January deliveries, a performance that officially pushed the Chinese electric vehicle maker past the one-million cumulative delivery mark.

XRP extended losses below $1.60 after failing to hold above $1.80, putting the $1.50 support level under renewed pressure.

Nomura said it has scaled back cryptocurrency exposure and tightened risk controls after losses at its European digital asset unit weighed on quarterly results.

The White House is planning talks with banking and crypto executives to break a dispute over stablecoin rules that has stalled progress on a major US Senate crypto bill.